Kamal A Hamed (Kamal Hamed, K Hamed)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 51

Top Venues

American journal of respiratory and critical care medicine

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

Mycoses

Basilea Pharmaceutica International Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Basilea Pharmaceutica International Ltd Apr 11 2017

Switzerland

Head of Clinical Development & Medical Affairs - Infectious Diseases :: Development & Medical Affairs

Publications

Sujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, Angela K Talley, Paul B Eckburg, Kathryn Liolios, Vipul K Gupta, Paul G Ambrose, Kamal A Hamed, David A Melnick
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis. Open forum infectious diseases 11 (9) (2024)
Nicole Cotroneo, Suzanne S Stokes, Michael J Pucci, Aileen Rubio, Kamal A Hamed, Ian A Critchley
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. The Journal of antimicrobial chemotherapy 79 (4) (2024)
Sujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, Angela K Talley, Paul B Eckburg, Kathryn Liolios, Vipul K Gupta, Paul G Ambrose, Kamal A Hamed, David A Melnick
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis. Open forum infectious diseases 11 (9) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American journal of respiratory and critical care medicine 209 (10) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American journal of respiratory and critical care medicine 209 (10) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-free DNA-based Detection of Mycobacterium Avium Complex Infection. American journal of respiratory and critical care medicine (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American journal of respiratory and critical care medicine 209 (10) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-free DNA-based Detection of Mycobacterium Avium Complex Infection. American journal of respiratory and critical care medicine (2024)
Nicole Cotroneo, Suzanne S Stokes, Michael J Pucci, Aileen Rubio, Kamal A Hamed, Ian A Critchley
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. The Journal of antimicrobial chemotherapy 79 (4) (2024)
Nicole Cotroneo, Suzanne S Stokes, Michael J Pucci, Aileen Rubio, Kamal A Hamed, Ian A Critchley
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. The Journal of antimicrobial chemotherapy 79 (4) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American journal of respiratory and critical care medicine 209 (10) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American journal of respiratory and critical care medicine 209 (10) (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-free DNA-based Detection of Mycobacterium Avium Complex Infection. American journal of respiratory and critical care medicine (2024)
Lin Li, Emily Henkle, Brady M Youngquist, Seungyeon Seo, Kamal A Hamed, David Melnick, Christopher J Lyon, Li Jiang, Adrian M Zelazny, Tony Y Hu, Kevin L Winthrop, Bo Ning
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American journal of respiratory and critical care medicine 209 (10) (2024)
Nicole Cotroneo, Suzanne S Stokes, Michael J Pucci, Aileen Rubio, Kamal A Hamed, Ian A Critchley
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. The Journal of antimicrobial chemotherapy (2024)
Keith A Rodvold, Justin Bader, Jon B Bruss, Kamal A Hamed
Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects. Antimicrobial agents and chemotherapy (2023)
David Melnick, Angela K Talley, Vipul K Gupta, Ian A Critchley, Paul B Eckburg, Kamal A Hamed, Nivedita Bhatt, Gary Moore, Daren Austin, Christopher M Rubino, Sujata M Bhavnani, Paul G Ambrose
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections. Antimicrobial agents and chemotherapy (2023)
Kamal A Hamed, Marc Engelhardt, Laura Lynn Kovanda, Jin Ju Huang, Jean Yan, Jalal A Aram
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies. Scientific reports 13 (1) (2023)
Kamal A Hamed, Marc Engelhardt, Laura Lynn Kovanda, Jin Ju Huang, Jean Yan, Jalal A Aram
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies. Scientific reports 13 (1) (2023)
Kamal A Hamed, Marc Engelhardt, Laura Lynn Kovanda, Jin Ju Huang, Jean Yan, Jalal A Aram
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies. Scientific reports 13 (1) (2023)
Kevin L Winthrop, Patrick Flume, Kamal A Hamed
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720. Expert review of anti-infective therapy (2023)
Kamal A Hamed, Glenn Tillotson
A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges. Expert review of respiratory medicine (2023)
Jon B Bruss, Justin Bader, Kamal A Hamed
Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment. Antimicrobial agents and chemotherapy (2023)
Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, Timothy C Jenkins, Nicholas A Turner, Helen W Boucher, Oleksander Pavlov, Ivan Titov, Serhii Kosulnykov, Boyko Atanasov, Ivan Poromanski, Manana Makhviladze, Anastasia Anderzhanova, Martin E Stryjewski, Maziar Assadi Gehr, Marc Engelhardt, Kamal A Hamed, Daniel Ionescu, Mark Jones, Mikael Saulay, Jennifer Smart, Harald Seifert, Vance G Fowler, null null
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. The New England journal of medicine (2023)
Rafael Cantón, Kamal A Hamed, Tatiana Wiktorowicz, Nowel Redder, Noelle Jemmely, Juan Quevedo, Anne Santerre Henriksen
In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016-19). JAC-antimicrobial resistance 4 (2) (2022)
Tobias Welte, Thomas Wl Scheeren, J Scott Overcash, Mikael Saulay, Marc Engelhardt, Kamal A Hamed
Efficacy and safety of ceftobiprole in patients aged 65 years or older: a post hoc analysis of three Phase III studies. Future microbiology 16 (2021)
Haihui Huang, Lei Gao, Marc Engelhardt, Mikael Saulay, Kamal A Hamed
A post hoc analysis of two Phase III trials showing the efficacy and tolerability of ceftobiprole in East Asian patients. Future microbiology 16 (2021)
Christopher M Rubino, Anthony P Cammarata, Anne Smits, Sebastian Schröpf, Mark Polak, Karine Litherland, Kamal A Hamed
Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients. Antimicrobial agents and chemotherapy 65 (11) (2021)
Jing Zhang, Yingyuan Zhang, Depei Wu, Guoying Cao, Kamal A Hamed, Amit Desai, Jalal A Aram, Xuan Guo, Rana Fayyad, Oliver Andreas Cornely
Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure-response analysis. Mycoses 64 (4) (2021)
Kamal A Hamed, Marc Engelhardt, Mark E Jones, Mikael Saulay, Thomas L Holland, Harald Seifert, Vance G Fowler
Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial. Future microbiology 15 (2020)
Kamal A Hamed, Tatiana Wiktorowicz, Maziar Assadi Gehr
No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials. Infection and drug resistance 13 (2020)
Robert K Flamm, Leonard R Duncan, Kamal A Hamed, Jennifer I Smart, Rodrigo E Mendes, Michael A Pfaller
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018. Antimicrobial agents and chemotherapy 64 (6) (2020)
Jannik Stemler, Kamal A Hamed, Jon Salmanton-García, Ali Rezaei-Matehkolaei, Stefanie K Grafe, Ertan Sal, Marouan Zarrouk, Danila Seidel, Reham Khedr, Ronen Ben-Ami, Eli Ben-Chetrit, Yehudah Roth, Oliver Andreas Cornely
Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature. Mycoses 63 (10) (2020)
Thomas W L Scheeren, Tobias Welte, Mikael Saulay, Marc Engelhardt, Anne Santerre-Henriksen, Kamal A Hamed
Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials. BMC infectious diseases 19 (1) (2019)
Marcio Nucci, Marc Engelhardt, Kamal A Hamed
Mucormycosis in South America: A review of 143 reported cases. Mycoses 62 (9) (2019)
Anne Santerre Henriksen, Jennifer Smart, Kamal A Hamed
Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 37 (9) (2018)
Srilekha Panguluri, Praveen Gunda, Laurie Debonnett, Kamal A Hamed
Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis. Clinical drug investigation 37 (8) (2018)
Michael A Pfaller, Robert K Flamm, Rodrigo E Mendes, Jennifer M Streit, Jennifer I Smart, Kamal A Hamed, Leonard R Duncan, Helio S Sader
Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016. Antimicrobial agents and chemotherapy 63 (1) (2018)
Tran Tinh Hien, Nicholas J White, Nguyen Thanh Thuy-Nhien, Nhu Thi Hoa, Phung Duc Thuan, Joel Tarning, François Nosten, Baldur Magnusson, Jay Prakash Jain, Kamal A Hamed
Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria. Antimicrobial agents and chemotherapy 61 (2) (2017)
Jia-Horng Kao, Tarik Asselah, Xiao-Guang Dou, Kamal A Hamed
Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model. Journal of gastroenterology and hepatology 32 (1) (2017)
Xiaoying Xu, Dmytro Khadzhynov, Harm Peters, Ricardo L Chaves, Kamal A Hamed, Micha Levi, Natascia Corti
Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy. British journal of clinical pharmacology 83 (3) (2016)
R Andrew Seaton, Armando Gonzalez-Ruiz, Kerry O Cleveland, Kimberly A Couch, Rashidkhan Pathan, Kamal A Hamed
Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE. Annals of clinical microbiology and antimicrobials 15 (2016)
Kamal A Hamed, Kelli Kuhen
No robust evidence of lumefantrine resistance. Antimicrobial agents and chemotherapy 59 (9) (2016)
Xieer Liang, Rong Fan, Jian Sun, Javed Shaikh, Ankush Taneja, Subhajit Gupta, Kamal A Hamed
Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis. Advances in therapy 33 (4) (2016)
S Banerjee, P Gunda, R F Drake, Kamal A Hamed
Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis. SpringerPlus 5 (1) (2016)
R Andrew Seaton, Francesco Menichetti, Georgios Dalekos, Andres Beiras-Fernandez, Francisco Nacinovich, Rashidkhan Pathan, Kamal A Hamed
Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience. Advances in therapy 32 (12) (2015)
Felix Keil, George L Daikos, Athanasios Skoutelis, Jose Ignacio Barranco Dominguez, Rashidkhan Pathan, Kamal A Hamed
Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry. Advances in therapy 32 (8) (2015)
K Malizos, J Sarma, R A Seaton, M Militz, F Menichetti, G Riccio, J Gaudias, U Trostmann, R Pathan, Kamal A Hamed
Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 35 (1) (2015)
Achyut Guleri, Riccardo Utili, Pascal Dohmen, Nicola Petrosillo, Cornelia Piper, Rashidkhan Pathan, Kamal A Hamed
Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE). Infectious diseases and therapy 4 (3) (2015)
Alberto Cogo, Armando Gonzalez-Ruiz, Rashidkhan Pathan, Kamal A Hamed
Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE). Infectious diseases and therapy 4 (3) (2015)
Christoph Lübbert, Arne C Rodloff, Kamal A Hamed
Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE). Infectious diseases and therapy 4 (3) (2015)

Kamal A Hamed.css-eqlu8i{font-size:small;padding-left:4px;} (Kamal Hamed, K Hamed)

Publication Activity (10 Years)

Top Topics

Top Venues

Kamal A Hamed (Kamal Hamed, K Hamed)